NCT06006039View on ClinicalTrials.gov

The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

January 1, 2027

Study Completion Date

November 1, 2027

Conditions

Crohn´s Disease

Trial Locations (2)

1105

RECRUITING

Amsterdam UMC, Amsterdam

1X5

RECRUITING

Mount Sinai, Toronto

All Listed Sponsors

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER